Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.
<h4>Background</h4>Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling.<h4>Methods and findings</h4>We collec...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2010
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2ca4514df5654d0f8402debb64314ded |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2ca4514df5654d0f8402debb64314ded |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2ca4514df5654d0f8402debb64314ded2021-11-18T07:03:17ZRisk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.1932-620310.1371/journal.pone.0013211https://doaj.org/article/2ca4514df5654d0f8402debb64314ded2010-10-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20976224/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling.<h4>Methods and findings</h4>We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand. Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region. Baseline immunity was measured from 521 sera collected during 2004 to April-2009. Haemagglutination inhibition (HI) antibody titres of ≥1:40 against 2009 H1N1 were considered seroprotective as well as seropositive. The overall community seroprevalence was 26.7% (CI:22.6-29.4). The seroprevalence varied across age and ethnicity. Children aged 5-19 years had the highest seroprevalence (46.7%;CI:38.3-55.0), a significant increase from the baseline (14%;CI:7.2-20.8). Older adults aged ≥60 had no significant difference in seroprevalence between the serosurvey (24.8%;CI:18.7-30.9) and baseline (22.6%;CI:15.3-30.0). Pacific peoples had the highest seroprevalence (49.5%;CI:35.1-64.0). There was no significant difference in seroprevalence between both primary (29.6%;CI:22.6-36.5) and secondary healthcare workers (25.3%;CI:20.8-29.8) and community participants. No significant regional variation was observed. Multivariate analysis indicated age as the most important risk factor followed by ethnicity. Previous seasonal influenza vaccination was associated with higher HI titres. Approximately 45.2% of seropositive individuals reported no symptoms.<h4>Conclusions</h4>Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1. Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three. Older people were protected due to pre-existing immunity. Age was the most important factor associated with infection followed by ethnicity. Healthcare workers did not appear to have an increased risk of infection compared with the general population.Don BandaranayakeQ Sue HuangAnge BissieloTim WoodGraham MackerethMichael G BakerRichard BeasleyStewart ReidSally RobertsVirginia Hope2009 H1N1 Serosurvey Investigation TeamPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 10, p e13211 (2010) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Don Bandaranayake Q Sue Huang Ange Bissielo Tim Wood Graham Mackereth Michael G Baker Richard Beasley Stewart Reid Sally Roberts Virginia Hope 2009 H1N1 Serosurvey Investigation Team Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. |
| description |
<h4>Background</h4>Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling.<h4>Methods and findings</h4>We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand. Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region. Baseline immunity was measured from 521 sera collected during 2004 to April-2009. Haemagglutination inhibition (HI) antibody titres of ≥1:40 against 2009 H1N1 were considered seroprotective as well as seropositive. The overall community seroprevalence was 26.7% (CI:22.6-29.4). The seroprevalence varied across age and ethnicity. Children aged 5-19 years had the highest seroprevalence (46.7%;CI:38.3-55.0), a significant increase from the baseline (14%;CI:7.2-20.8). Older adults aged ≥60 had no significant difference in seroprevalence between the serosurvey (24.8%;CI:18.7-30.9) and baseline (22.6%;CI:15.3-30.0). Pacific peoples had the highest seroprevalence (49.5%;CI:35.1-64.0). There was no significant difference in seroprevalence between both primary (29.6%;CI:22.6-36.5) and secondary healthcare workers (25.3%;CI:20.8-29.8) and community participants. No significant regional variation was observed. Multivariate analysis indicated age as the most important risk factor followed by ethnicity. Previous seasonal influenza vaccination was associated with higher HI titres. Approximately 45.2% of seropositive individuals reported no symptoms.<h4>Conclusions</h4>Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1. Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three. Older people were protected due to pre-existing immunity. Age was the most important factor associated with infection followed by ethnicity. Healthcare workers did not appear to have an increased risk of infection compared with the general population. |
| format |
article |
| author |
Don Bandaranayake Q Sue Huang Ange Bissielo Tim Wood Graham Mackereth Michael G Baker Richard Beasley Stewart Reid Sally Roberts Virginia Hope 2009 H1N1 Serosurvey Investigation Team |
| author_facet |
Don Bandaranayake Q Sue Huang Ange Bissielo Tim Wood Graham Mackereth Michael G Baker Richard Beasley Stewart Reid Sally Roberts Virginia Hope 2009 H1N1 Serosurvey Investigation Team |
| author_sort |
Don Bandaranayake |
| title |
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. |
| title_short |
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. |
| title_full |
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. |
| title_fullStr |
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. |
| title_full_unstemmed |
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. |
| title_sort |
risk factors and immunity in a nationally representative population following the 2009 influenza a(h1n1) pandemic. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2010 |
| url |
https://doaj.org/article/2ca4514df5654d0f8402debb64314ded |
| work_keys_str_mv |
AT donbandaranayake riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT qsuehuang riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT angebissielo riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT timwood riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT grahammackereth riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT michaelgbaker riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT richardbeasley riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT stewartreid riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT sallyroberts riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT virginiahope riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic AT 2009h1n1serosurveyinvestigationteam riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic |
| _version_ |
1718423968638042112 |